Negative regulation of glycolytic process

pathway activity — cross-omics
GO:0045820Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of glycolytic process pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are DAB2, ZNF451, and COLGALT1, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of glycolytic process activity versus DAB2 in GBM (Pearson r = 0.54).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMDAB2 →+0.506+0.050<.001<.00134
GBMZNF451 →-0.281-0.069.001<.00134
GBMCOLGALT1 →+0.377+0.050<.001<.00134
LSCCC1R →+0.474+0.052.001.00134
GBMFOSL2_S200 →+0.428+0.056<.001<.00134
OVGRIP1_S847 →+0.960+0.042.005<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0045820 vs DAB2 — GBM

Per-sample scatter of Negative regulation of glycolytic process activity vs DAB2 in GBM.

Explore this scatter interactively →

Exploration